Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy-Reference-Cited by-同舟云学术

Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

Published:2014-05-06 Issue:16 Volume:120 Page:2403-2411
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kidwell Kelley M.¹,Harte Steven E.²,Hayes Daniel F.³,Storniolo Anna Maria⁴,Carpenter Janet⁵,Flockhart David A.⁶,Stearns Vered⁷,Clauw Daniel J.²,Williams David A.²,Henry N. Lynn³

Affiliation:

1. Department of Biostatistics; University of Michigan School of Public Health; Ann Arbor Michigan

2. Chronic Pain and Fatigue Research Center; University of Michigan; Ann Arbor Michigan

3. Breast Oncology Program; University of Michigan Comprehensive Cancer Center; Ann Arbor Michigan

4. Melvin and Bren Simon Cancer Center; Indiana University School of Medicine; Indianapolis Indiana

5. Center for Enhancing Quality of Life in Chronic Illness, School of Nursing; Indiana University; Indiana

6. Division of Clinical Pharmacology, Department of Medicine; Indiana University School of Medicine; Indianapolis Indiana

7. Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University; Baltimore Maryland

Funder

Damon Runyon Cancer Research Foundation

National Institute of General Medical Sciences

Pfizer

Novartis

Fashion Footwear Association of New York/QVC Presents Shoes on Sale

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28756/fullpdf

Reference33 articles.

1. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer;Burstein;J Clin Oncol.,2010

2. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen;Dowsett;J Clin Oncol.,2010

3. Predictors of aromatase inhibitor discontinuation due to treatment-emergent symptoms in early-stage breast cancer;Henry;J Clin Oncol.,2012

4. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer;Partridge;J Clin Oncol.,2008

5. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer;Hershman;Breast Cancer Res Treat.,2011

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sleep oscillations related to memory consolidation during aromatases inhibitors for breast cancer;Sleep Medicine;2024-09

2. Effects of concurrent aerobic and strength training in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis;Journal of Cancer Survivorship;2024-07-06

3. A Prospective Study of Sleep Quality in Women Undergoing Chemotherapy for Breast, Ovarian, and Endometrial Cancer;2024-02-22

4. Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer;Breast Cancer Research and Treatment;2024-01-10